APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Therapy (IV) Bottles

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Intravenous Therapy (IV) Bottles Market Outlook and Growth Opportunities 2026

Report ID 17442575054 July 2026194 pages

Choose your research edition.

Industry ResearchIntravenous Therapy (IV) Bottles Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Therapy (IV) Bottles Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Intravenous Therapy (IV) Bottles Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Therapy (IV) Bottles Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Therapy (IV) Bottles Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Intravenous Therapy (IV) Bottles market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Intravenous Therapy (IV) Bottles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intravenous Therapy (IV) Bottles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Therapy (IV) Bottles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Intravenous Therapy (IV) Bottles market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Intravenous Therapy (IV) Bottles market include Vioser SA, Technoflex S.A, Sippex, Polycine GmbH, Metrix Company, Medicopack A/S, Kraton Corporation, JW Life Science and JOTOP Glass, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intravenous Therapy (IV) Bottles market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intravenous Therapy (IV) Bottles and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Therapy (IV) Bottles sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Therapy (IV) Bottles market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Therapy (IV) Bottles Segment by Company

Vioser SA

Technoflex S.A

Sippex

Polycine GmbH

Metrix Company

Medicopack A/S

Kraton Corporation

JW Life Science

JOTOP Glass

ICU Medical

Fresenius AG

Euro Healthcare Pvt. Ltd.

Baxter Healthcare Limited

Bausch Group

B. Braun

Intravenous Therapy (IV) Bottles Segment by Type

Plastic IV Bottles

Glass IV Bottle

Intravenous Therapy (IV) Bottles Segment by Application

Hospital

Clinic

Others

Intravenous Therapy (IV) Bottles Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Intravenous Therapy (IV) Bottles status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Intravenous Therapy (IV) Bottles market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Intravenous Therapy (IV) Bottles significant trends, drivers, influence factors in global and regions.

6. To analyze Intravenous Therapy (IV) Bottles competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Therapy (IV) Bottles market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Therapy (IV) Bottles and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Therapy (IV) Bottles.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous Therapy (IV) Bottles market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intravenous Therapy (IV) Bottles industry.

Chapter 3: Detailed analysis of Intravenous Therapy (IV) Bottles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Intravenous Therapy (IV) Bottles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Intravenous Therapy (IV) Bottles in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Intravenous Therapy (IV) Bottles Industry Trends Table 2. Intravenous Therapy (IV) Bottles Industry Drivers Table 3. Intravenous Therapy (IV) Bottles Industry Opportunities and Challenges Table 4. Intravenous Therapy (IV) Bottles Industry Restraints Table 5. Global Intravenous Therapy (IV) Bottles Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Intravenous Therapy (IV) Bottles Revenue Share by Company (2021-2026) Table 7. Global Intravenous Therapy (IV) Bottles Sales Volume by Company (k units) & (2021-2026) Table 8. Global Intravenous Therapy (IV) Bottles Sales Volume Share by Company (2021-2026) Table 9. Global Intravenous Therapy (IV) Bottles Average Price (USD/unit) of Company (2021-2026) Table 10. Global Intravenous Therapy (IV) Bottles Company Ranking, (2024-2026) & (USD Million) Table 11. Global Intravenous Therapy (IV) Bottles Key Company Manufacturing Base & Headquarters Table 12. Global Intravenous Therapy (IV) Bottles Company, Product Type & Application Table 13. Global Intravenous Therapy (IV) Bottles Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous Therapy (IV) Bottles by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plastic IV Bottles Table 18. Significant Companies of Glass IV Bottle Table 19. Global Intravenous Therapy (IV) Bottles Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Intravenous Therapy (IV) Bottles Sales Volume by Type (2021-2026) & (k units) Table 21. Global Intravenous Therapy (IV) Bottles Sales Volume by Type (2027-2032) & (k units) Table 22. Global Intravenous Therapy (IV) Bottles Sales Volume Share by Type (2021-2026) Table 23. Global Intravenous Therapy (IV) Bottles Sales Volume Share by Type (2027-2032) Table 24. Global Intravenous Therapy (IV) Bottles Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Intravenous Therapy (IV) Bottles Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Intravenous Therapy (IV) Bottles Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Intravenous Therapy (IV) Bottles Sales Value Share by Type (2021-2026) Table 28. Global Intravenous Therapy (IV) Bottles Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Others Table 32. Global Intravenous Therapy (IV) Bottles Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Intravenous Therapy (IV) Bottles Sales Volume by Application (2021-2026) & (k units) Table 34. Global Intravenous Therapy (IV) Bottles Sales Volume by Application (2027-2032) & (k units) Table 35. Global Intravenous Therapy (IV) Bottles Sales Volume Share by Application (2021-2026) Table 36. Global Intravenous Therapy (IV) Bottles Sales Volume Share by Application (2027-2032) Table 37. Global Intravenous Therapy (IV) Bottles Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Intravenous Therapy (IV) Bottles Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Intravenous Therapy (IV) Bottles Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Intravenous Therapy (IV) Bottles Sales Value Share by Application (2021-2026) Table 41. Global Intravenous Therapy (IV) Bottles Sales Value Share by Application (2027-2032) Table 42. Global Intravenous Therapy (IV) Bottles Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Intravenous Therapy (IV) Bottles Sales by Region (2021-2026) & (k units) Table 44. Global Intravenous Therapy (IV) Bottles Sales Market Share by Region (2021-2026) Table 45. Global Intravenous Therapy (IV) Bottles Sales by Region (2027-2032) & (k units) Table 46. Global Intravenous Therapy (IV) Bottles Sales Market Share by Region (2027-2032) Table 47. Global Intravenous Therapy (IV) Bottles Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Intravenous Therapy (IV) Bottles Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Intravenous Therapy (IV) Bottles Sales Value Share by Region (2021-2026) Table 50. Global Intravenous Therapy (IV) Bottles Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Intravenous Therapy (IV) Bottles Sales Value Share by Region (2027-2032) Table 52. Global Intravenous Therapy (IV) Bottles Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Intravenous Therapy (IV) Bottles Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Intravenous Therapy (IV) Bottles Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Intravenous Therapy (IV) Bottles Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 57. Global Intravenous Therapy (IV) Bottles Sales Market Share by Country (2021-2026) Table 58. Global Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 59. Global Intravenous Therapy (IV) Bottles Sales Market Share by Country (2027-2032) Table 60. Global Intravenous Therapy (IV) Bottles Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Intravenous Therapy (IV) Bottles Sales Value Market Share by Country (2021-2026) Table 62. Global Intravenous Therapy (IV) Bottles Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Intravenous Therapy (IV) Bottles Sales Value Market Share by Country (2027-2032) Table 64. Vioser SA Company Information Table 65. Vioser SA Business Overview Table 66. Vioser SA Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Vioser SA Intravenous Therapy (IV) Bottles Product Portfolio Table 68. Vioser SA Recent Development Table 69. Technoflex S.A Company Information Table 70. Technoflex S.A Business Overview Table 71. Technoflex S.A Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Technoflex S.A Intravenous Therapy (IV) Bottles Product Portfolio Table 73. Technoflex S.A Recent Development Table 74. Sippex Company Information Table 75. Sippex Business Overview Table 76. Sippex Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Sippex Intravenous Therapy (IV) Bottles Product Portfolio Table 78. Sippex Recent Development Table 79. Polycine GmbH Company Information Table 80. Polycine GmbH Business Overview Table 81. Polycine GmbH Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Polycine GmbH Intravenous Therapy (IV) Bottles Product Portfolio Table 83. Polycine GmbH Recent Development Table 84. Metrix Company Company Information Table 85. Metrix Company Business Overview Table 86. Metrix Company Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Metrix Company Intravenous Therapy (IV) Bottles Product Portfolio Table 88. Metrix Company Recent Development Table 89. Medicopack A/S Company Information Table 90. Medicopack A/S Business Overview Table 91. Medicopack A/S Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Medicopack A/S Intravenous Therapy (IV) Bottles Product Portfolio Table 93. Medicopack A/S Recent Development Table 94. Kraton Corporation Company Information Table 95. Kraton Corporation Business Overview Table 96. Kraton Corporation Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Kraton Corporation Intravenous Therapy (IV) Bottles Product Portfolio Table 98. Kraton Corporation Recent Development Table 99. JW Life Science Company Information Table 100. JW Life Science Business Overview Table 101. JW Life Science Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. JW Life Science Intravenous Therapy (IV) Bottles Product Portfolio Table 103. JW Life Science Recent Development Table 104. JOTOP Glass Company Information Table 105. JOTOP Glass Business Overview Table 106. JOTOP Glass Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. JOTOP Glass Intravenous Therapy (IV) Bottles Product Portfolio Table 108. JOTOP Glass Recent Development Table 109. ICU Medical Company Information Table 110. ICU Medical Business Overview Table 111. ICU Medical Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. ICU Medical Intravenous Therapy (IV) Bottles Product Portfolio Table 113. ICU Medical Recent Development Table 114. Fresenius AG Company Information Table 115. Fresenius AG Business Overview Table 116. Fresenius AG Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Fresenius AG Intravenous Therapy (IV) Bottles Product Portfolio Table 118. Fresenius AG Recent Development Table 119. Euro Healthcare Pvt. Ltd. Company Information Table 120. Euro Healthcare Pvt. Ltd. Business Overview Table 121. Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Product Portfolio Table 123. Euro Healthcare Pvt. Ltd. Recent Development Table 124. Baxter Healthcare Limited Company Information Table 125. Baxter Healthcare Limited Business Overview Table 126. Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Product Portfolio Table 128. Baxter Healthcare Limited Recent Development Table 129. Bausch Group Company Information Table 130. Bausch Group Business Overview Table 131. Bausch Group Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Bausch Group Intravenous Therapy (IV) Bottles Product Portfolio Table 133. Bausch Group Recent Development Table 134. B. Braun Company Information Table 135. B. Braun Business Overview Table 136. B. Braun Intravenous Therapy (IV) Bottles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. B. Braun Intravenous Therapy (IV) Bottles Product Portfolio Table 138. B. Braun Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Intravenous Therapy (IV) Bottles Distributors List Table 142. Intravenous Therapy (IV) Bottles Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Intravenous Therapy (IV) Bottles Product Image Figure 2. Global Intravenous Therapy (IV) Bottles Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Therapy (IV) Bottles Sales Value (2021-2032) & (US$ Million) Figure 4. Global Intravenous Therapy (IV) Bottles Sales (2021-2032) & (k units) Figure 5. Global Intravenous Therapy (IV) Bottles Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Intravenous Therapy (IV) Bottles Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plastic IV Bottles Image Figure 10. Glass IV Bottle Image Figure 11. Global Intravenous Therapy (IV) Bottles Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Intravenous Therapy (IV) Bottles Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Intravenous Therapy (IV) Bottles Sales Volume Share by Type (2021-2032) Figure 14. Global Intravenous Therapy (IV) Bottles Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Intravenous Therapy (IV) Bottles Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Intravenous Therapy (IV) Bottles Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Intravenous Therapy (IV) Bottles Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Intravenous Therapy (IV) Bottles Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Intravenous Therapy (IV) Bottles Sales Volume Share by Application (2021-2032) Figure 23. Global Intravenous Therapy (IV) Bottles Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Intravenous Therapy (IV) Bottles Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Intravenous Therapy (IV) Bottles Sales Value Share by Application (2021-2032) Figure 26. Global Intravenous Therapy (IV) Bottles Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Intravenous Therapy (IV) Bottles Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Intravenous Therapy (IV) Bottles Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Intravenous Therapy (IV) Bottles Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Intravenous Therapy (IV) Bottles Sales Value (2021-2032) & (US$ Million) Figure 31. North America Intravenous Therapy (IV) Bottles Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Intravenous Therapy (IV) Bottles Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Intravenous Therapy (IV) Bottles Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Intravenous Therapy (IV) Bottles Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Intravenous Therapy (IV) Bottles Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Intravenous Therapy (IV) Bottles Sales Value (2021-2032) & (US$ Million) Figure 37. South America Intravenous Therapy (IV) Bottles Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Intravenous Therapy (IV) Bottles Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Intravenous Therapy (IV) Bottles Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Intravenous Therapy (IV) Bottles Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Intravenous Therapy (IV) Bottles Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Plastic IV Bottles
  • Glass IV Bottle
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Vioser SA
  • Technoflex S.A
  • Sippex
  • Polycine GmbH
  • Metrix Company
  • Medicopack A/S
  • Kraton Corporation
  • JW Life Science
  • JOTOP Glass
  • ICU Medical
  • Fresenius AG
  • Euro Healthcare Pvt. Ltd.
  • Baxter Healthcare Limited
  • Bausch Group
  • B. Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Therapy (IV) Bottles Sales Value (2021-2032)
  4. 1.2.2 Global Intravenous Therapy (IV) Bottles Sales Volume (2021-2032)
  5. 1.2.3 Global Intravenous Therapy (IV) Bottles Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Intravenous Therapy (IV) Bottles Market Dynamics
  1. 2.1 Intravenous Therapy (IV) Bottles Industry Trends
  2. 2.2 Intravenous Therapy (IV) Bottles Industry Drivers
  3. 2.3 Intravenous Therapy (IV) Bottles Industry Opportunities and Challenges
  4. 2.4 Intravenous Therapy (IV) Bottles Industry Restraints
3 Intravenous Therapy (IV) Bottles Market by Company
  1. 3.1 Global Intravenous Therapy (IV) Bottles Company Revenue Ranking in 2025
  2. 3.2 Global Intravenous Therapy (IV) Bottles Revenue by Company (2021-2026)
  3. 3.3 Global Intravenous Therapy (IV) Bottles Sales Volume by Company (2021-2026)
  4. 3.4 Global Intravenous Therapy (IV) Bottles Average Price by Company (2021-2026)
  5. 3.5 Global Intravenous Therapy (IV) Bottles Company Ranking (2024-2026)
  6. 3.6 Global Intravenous Therapy (IV) Bottles Company Manufacturing Base and Headquarters
  7. 3.7 Global Intravenous Therapy (IV) Bottles Company Product Type and Application
  8. 3.8 Global Intravenous Therapy (IV) Bottles Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Intravenous Therapy (IV) Bottles Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Intravenous Therapy (IV) Bottles Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Intravenous Therapy (IV) Bottles Market by Type
  1. 4.1 Intravenous Therapy (IV) Bottles Type Introduction
  2. 4.1.1 Plastic IV Bottles
  3. 4.1.2 Glass IV Bottle
  4. 4.2 Global Intravenous Therapy (IV) Bottles Sales Volume by Type
  5. 4.2.1 Global Intravenous Therapy (IV) Bottles Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Intravenous Therapy (IV) Bottles Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Intravenous Therapy (IV) Bottles Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Intravenous Therapy (IV) Bottles Sales Value by Type
  9. 4.3.1 Global Intravenous Therapy (IV) Bottles Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Intravenous Therapy (IV) Bottles Sales Value by Type (2021-2032)
  11. 4.3.3 Global Intravenous Therapy (IV) Bottles Sales Value Share by Type (2021-2032)
5 Intravenous Therapy (IV) Bottles Market by Application
  1. 5.1 Intravenous Therapy (IV) Bottles Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Intravenous Therapy (IV) Bottles Sales Volume by Application
  6. 5.2.1 Global Intravenous Therapy (IV) Bottles Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Therapy (IV) Bottles Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Intravenous Therapy (IV) Bottles Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Intravenous Therapy (IV) Bottles Sales Value by Application
  10. 5.3.1 Global Intravenous Therapy (IV) Bottles Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Intravenous Therapy (IV) Bottles Sales Value by Application (2021-2032)
  12. 5.3.3 Global Intravenous Therapy (IV) Bottles Sales Value Share by Application (2021-2032)
6 Intravenous Therapy (IV) Bottles Regional Sales and Value Analysis
  1. 6.1 Global Intravenous Therapy (IV) Bottles Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Therapy (IV) Bottles Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous Therapy (IV) Bottles Sales by Region: 2021-2026
  4. 6.2.2 Global Intravenous Therapy (IV) Bottles Sales by Region (2027-2032)
  5. 6.3 Global Intravenous Therapy (IV) Bottles Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Intravenous Therapy (IV) Bottles Sales Value by Region (2021-2032)
  7. 6.4.1 Global Intravenous Therapy (IV) Bottles Sales Value by Region: 2021-2026
  8. 6.4.2 Global Intravenous Therapy (IV) Bottles Sales Value by Region (2027-2032)
  9. 6.5 Global Intravenous Therapy (IV) Bottles Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Intravenous Therapy (IV) Bottles Sales Value (2021-2032)
  12. 6.6.2 North America Intravenous Therapy (IV) Bottles Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Intravenous Therapy (IV) Bottles Sales Value (2021-2032)
  15. 6.7.2 Europe Intravenous Therapy (IV) Bottles Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Intravenous Therapy (IV) Bottles Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Intravenous Therapy (IV) Bottles Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Intravenous Therapy (IV) Bottles Sales Value (2021-2032)
  21. 6.9.2 South America Intravenous Therapy (IV) Bottles Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Intravenous Therapy (IV) Bottles Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Intravenous Therapy (IV) Bottles Sales Value Share by Country, 2025 VS 2032
7 Intravenous Therapy (IV) Bottles Country-level Sales and Value Analysis
  1. 7.1 Global Intravenous Therapy (IV) Bottles Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Intravenous Therapy (IV) Bottles Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Intravenous Therapy (IV) Bottles Sales by Country (2021-2032)
  4. 7.3.1 Global Intravenous Therapy (IV) Bottles Sales by Country (2021-2026)
  5. 7.3.2 Global Intravenous Therapy (IV) Bottles Sales by Country (2027-2032)
  6. 7.4 Global Intravenous Therapy (IV) Bottles Sales Value by Country (2021-2032)
  7. 7.4.1 Global Intravenous Therapy (IV) Bottles Sales Value by Country (2021-2026)
  8. 7.4.2 Global Intravenous Therapy (IV) Bottles Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Intravenous Therapy (IV) Bottles Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Intravenous Therapy (IV) Bottles Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Intravenous Therapy (IV) Bottles Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Vioser SA
  2. 8.1.1 Vioser SA Company Information
  3. 8.1.2 Vioser SA Business Overview
  4. 8.1.3 Vioser SA Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Vioser SA Intravenous Therapy (IV) Bottles Product Portfolio
  6. 8.1.5 Vioser SA Recent Developments
  7. 8.2 Technoflex S.A
  8. 8.2.1 Technoflex S.A Company Information
  9. 8.2.2 Technoflex S.A Business Overview
  10. 8.2.3 Technoflex S.A Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Technoflex S.A Intravenous Therapy (IV) Bottles Product Portfolio
  12. 8.2.5 Technoflex S.A Recent Developments
  13. 8.3 Sippex
  14. 8.3.1 Sippex Company Information
  15. 8.3.2 Sippex Business Overview
  16. 8.3.3 Sippex Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sippex Intravenous Therapy (IV) Bottles Product Portfolio
  18. 8.3.5 Sippex Recent Developments
  19. 8.4 Polycine GmbH
  20. 8.4.1 Polycine GmbH Company Information
  21. 8.4.2 Polycine GmbH Business Overview
  22. 8.4.3 Polycine GmbH Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Polycine GmbH Intravenous Therapy (IV) Bottles Product Portfolio
  24. 8.4.5 Polycine GmbH Recent Developments
  25. 8.5 Metrix Company
  26. 8.5.1 Metrix Company Company Information
  27. 8.5.2 Metrix Company Business Overview
  28. 8.5.3 Metrix Company Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Metrix Company Intravenous Therapy (IV) Bottles Product Portfolio
  30. 8.5.5 Metrix Company Recent Developments
  31. 8.6 Medicopack A/S
  32. 8.6.1 Medicopack A/S Company Information
  33. 8.6.2 Medicopack A/S Business Overview
  34. 8.6.3 Medicopack A/S Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Medicopack A/S Intravenous Therapy (IV) Bottles Product Portfolio
  36. 8.6.5 Medicopack A/S Recent Developments
  37. 8.7 Kraton Corporation
  38. 8.7.1 Kraton Corporation Company Information
  39. 8.7.2 Kraton Corporation Business Overview
  40. 8.7.3 Kraton Corporation Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kraton Corporation Intravenous Therapy (IV) Bottles Product Portfolio
  42. 8.7.5 Kraton Corporation Recent Developments
  43. 8.8 JW Life Science
  44. 8.8.1 JW Life Science Company Information
  45. 8.8.2 JW Life Science Business Overview
  46. 8.8.3 JW Life Science Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 JW Life Science Intravenous Therapy (IV) Bottles Product Portfolio
  48. 8.8.5 JW Life Science Recent Developments
  49. 8.9 JOTOP Glass
  50. 8.9.1 JOTOP Glass Company Information
  51. 8.9.2 JOTOP Glass Business Overview
  52. 8.9.3 JOTOP Glass Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 JOTOP Glass Intravenous Therapy (IV) Bottles Product Portfolio
  54. 8.9.5 JOTOP Glass Recent Developments
  55. 8.10 ICU Medical
  56. 8.10.1 ICU Medical Company Information
  57. 8.10.2 ICU Medical Business Overview
  58. 8.10.3 ICU Medical Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ICU Medical Intravenous Therapy (IV) Bottles Product Portfolio
  60. 8.10.5 ICU Medical Recent Developments
  61. 8.11 Fresenius AG
  62. 8.11.1 Fresenius AG Company Information
  63. 8.11.2 Fresenius AG Business Overview
  64. 8.11.3 Fresenius AG Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Fresenius AG Intravenous Therapy (IV) Bottles Product Portfolio
  66. 8.11.5 Fresenius AG Recent Developments
  67. 8.12 Euro Healthcare Pvt. Ltd.
  68. 8.12.1 Euro Healthcare Pvt. Ltd. Company Information
  69. 8.12.2 Euro Healthcare Pvt. Ltd. Business Overview
  70. 8.12.3 Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Product Portfolio
  72. 8.12.5 Euro Healthcare Pvt. Ltd. Recent Developments
  73. 8.13 Baxter Healthcare Limited
  74. 8.13.1 Baxter Healthcare Limited Company Information
  75. 8.13.2 Baxter Healthcare Limited Business Overview
  76. 8.13.3 Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Product Portfolio
  78. 8.13.5 Baxter Healthcare Limited Recent Developments
  79. 8.14 Bausch Group
  80. 8.14.1 Bausch Group Company Information
  81. 8.14.2 Bausch Group Business Overview
  82. 8.14.3 Bausch Group Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bausch Group Intravenous Therapy (IV) Bottles Product Portfolio
  84. 8.14.5 Bausch Group Recent Developments
  85. 8.15 B. Braun
  86. 8.15.1 B. Braun Company Information
  87. 8.15.2 B. Braun Business Overview
  88. 8.15.3 B. Braun Intravenous Therapy (IV) Bottles Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 B. Braun Intravenous Therapy (IV) Bottles Product Portfolio
  90. 8.15.5 B. Braun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous Therapy (IV) Bottles Value Chain Analysis
  2. 9.1.1 Intravenous Therapy (IV) Bottles Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous Therapy (IV) Bottles Sales Mode & Process
  6. 9.2 Intravenous Therapy (IV) Bottles Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous Therapy (IV) Bottles Distributors
  9. 9.2.3 Intravenous Therapy (IV) Bottles Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst